Andersons pediatric cardiology 1832

ofbilateralpulmonaryarterybandingforinitial
palliationinsingle-ventricleneonatesand
infants:riskfactorsformortalitybeforethe
bidirectionalGlennprocedure.Interact
CardiovascThoracSurg.2014;19:807–811.
6.FuchigamiT,NishiokaM,AkashigiT,etal.
Growingpotentialofsmallaorticvalvewith
aorticcoarctationorinterruptedaorticarchafter
bilateralpulmonaryarterybanding.Interact
CardiovascThoracSurg.2016;23:668–693.
7.TweddellJS,HoffmanGM,FedderlyRT,etal.
Phenoxybenzamineimprovessystemicoxygen
deliveryaftertheNorwoodprocedure.Ann
ThoracSurg.1999;67:161–167.
8.MottaP,MossadE,ToscanaD,ZestosM,Mee
R.Comparisonofphenoxybenzaminetosodium
nitroprussideininfantsundergoingsurgery.J
CardiothoracVascAnesth.2005;19:54–59.
9.GhanayemNS,HoffmanGM,MussattoKA,et
al.Homesurveillanceprogramprevents
interstagemortalityaftertheNorwood
procedure.JThoracCardiovascSurg.
2003;1367–1375.
10.KauwD,KooleMAC,vanDorthJR,etal.
eHealthinpatientswithcongenitalheartdisease:
areview.ExpertRevCardiovascTher.
2018;16:627–634.


11.RossiAF,KhanDM,HannanR,etal.Goaldirectedmedicaltherapyandpoint-of-care
testingimproveoutcomesaftercongenitalheart

surgery.IntensiveCareMed.2005;31:98–104.
12.SchwartzI,McCrackenCE,PetitCJ,etal.Late
outcomesaftertheFontanprocedureinpatients
withsingleventricle:ameta-analysis.Heart.
2018;104:1508–1514.
13.AtzAM,ZakV,MahonyL,etal.Longitudinal
outcomesofpatientswithsingleventricleafter
theFontanprocedure.JAmCollCardiol.
2017;69(22):2735–2744.
14.NewburgerJW,SleeperLA,GaynorJW.
Transplant-freesurvivalandinterventionsat6
yearsintheSVRtrial.Circulation.
2018;137:2246–2253.
15.HasegawaT,MasudaM,OkumuraM,etal.
Trendsandoutcomesinneonatalcardiacsurgery
forcongenitalheartdiseaseinJapanfrom1996
to2010.EurJCardiothoracicSurg.
2016;51:301–307.
16.AgarwalHS,WolframKB,SavilleBR,Donahue
BS,BichellDP.Postoperativecomplicationsand
associationwithoutcomesinpediatriccardiac
surgery.JThoracCardiovascSurg.
2014;148:609–616.
17.JacobsJP,Lacour-GayetFG,JacobsML,etal.


InitialapplicationintheSTScongenitaldatabase
ofcomplexityadjustmenttoevaluatesurgical
casemixandresults.AnnThoracSurg.
2005;79:1635–1649.

18.JacobsJP,O'BrienSM,PasqualiSK,etal.
Variationinoutcomesforbenchmarkoperations:
ananalysisofthesocietyofthoracicsurgeons
congenitalheartsurgerydatabase.AnnThorac
Surg.2011;92:2184–2192.
19.JacobsJP,MayerJEJr,MavroudisC,etal.The
societyofthoracicsurgeonscongenitalheart
surgerydatabase:2017updateonoutcomesand
quality.AnnThoracSurg.2017;103:699–709.
20.DuPlessisK,PetersR,KingI,etal.“Howlong
willIcontinuetobenormal?”Adultswitha
Fontancirculation'sgreatestconcerns.IntJ
Cardiol.2018;260:54–59.
21.Knott-CraigCJ,DanielsonGK,SchaffHV,etal.
ThemodifiedFontanoperation:ananalysisof
riskfactorsforearlypostoperativedeathor
takedownin702consecutivepatientsfromone
institution.JThoracCardiovascSurg.
1995;109:1237–1243.
22.DowningTE,AllenKY,GlatzAC,etal.LongtermsurvivalaftertheFontanoperation:twenty
yearsofexperienceatasinglecenter.JThorac
CardiovascSurg.2017;154:243–253.